NZ501987A - Single, high dosage intravenous administration of estramustine phosphate - Google Patents
Single, high dosage intravenous administration of estramustine phosphateInfo
- Publication number
- NZ501987A NZ501987A NZ501987A NZ50198799A NZ501987A NZ 501987 A NZ501987 A NZ 501987A NZ 501987 A NZ501987 A NZ 501987A NZ 50198799 A NZ50198799 A NZ 50198799A NZ 501987 A NZ501987 A NZ 501987A
- Authority
- NZ
- New Zealand
- Prior art keywords
- intravenous administration
- estramustine phosphate
- high dosage
- dosage intravenous
- estramustine
- Prior art date
Links
- 229960004750 estramustine phosphate Drugs 0.000 title abstract 2
- ADFOJJHRTBFFOF-RBRWEJTLSA-N estramustine phosphate Chemical compound ClCCN(CCCl)C(=O)OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)OP(O)(O)=O)[C@@H]4[C@@H]3CCC2=C1 ADFOJJHRTBFFOF-RBRWEJTLSA-N 0.000 title abstract 2
- 238000001990 intravenous administration Methods 0.000 title abstract 2
- 229940124650 anti-cancer therapies Drugs 0.000 abstract 1
- 238000011319 anticancer therapy Methods 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7954298P | 1998-03-27 | 1998-03-27 | |
| PCT/US1999/004275 WO1999049869A1 (en) | 1998-03-27 | 1999-03-26 | Methods to potentiate intravenous estramustine phosphate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ501987A true NZ501987A (en) | 2002-10-25 |
Family
ID=22151209
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ501987A NZ501987A (en) | 1998-03-27 | 1999-03-26 | Single, high dosage intravenous administration of estramustine phosphate |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1003521A4 (xx) |
| JP (1) | JP2001508810A (xx) |
| KR (1) | KR20010021656A (xx) |
| CN (2) | CN1273530A (xx) |
| AU (1) | AU750010B2 (xx) |
| BR (1) | BR9906425A (xx) |
| CA (1) | CA2295049A1 (xx) |
| EA (1) | EA004647B1 (xx) |
| HU (1) | HUP0200547A3 (xx) |
| ID (1) | ID24504A (xx) |
| IL (1) | IL133612A0 (xx) |
| NO (1) | NO20002343L (xx) |
| NZ (1) | NZ501987A (xx) |
| PL (1) | PL342969A1 (xx) |
| WO (1) | WO1999049869A1 (xx) |
| ZA (1) | ZA997821B (xx) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0003201D0 (en) * | 2000-02-11 | 2000-04-05 | Pharmacia & Upjohn Spa | Method to potentiate the therapeutic efficacy of taxane and derivatives thereof |
| US6436913B1 (en) * | 2000-07-25 | 2002-08-20 | Pharmacia & Upjohn Company | Use of estramustine phosphate in the treatment of bone metastasis |
| RU2471511C1 (ru) * | 2011-05-04 | 2013-01-10 | Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения и социального развития Российской Федерации (ФГБУ "РНИОИ" Минздравсоцразвития России) | Способ лечения метастазов в печень рака толстой кишки |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS617292A (ja) * | 1984-06-20 | 1986-01-13 | Japan Atom Energy Res Inst | 制癌剤を結合させたエストラサイト系化合物を製造する方法 |
| US5077056A (en) * | 1984-08-08 | 1991-12-31 | The Liposome Company, Inc. | Encapsulation of antineoplastic agents in liposomes |
| MX9203808A (es) * | 1987-03-05 | 1992-07-01 | Liposome Co Inc | Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos. |
| ATE194767T1 (de) * | 1992-03-23 | 2000-08-15 | Univ Georgetown | In liposomen verkapseltes taxol und verwendungsverfahren |
| FR2697752B1 (fr) * | 1992-11-10 | 1995-04-14 | Rhone Poulenc Rorer Sa | Compositions antitumorales contenant des dérivés du taxane. |
-
1999
- 1999-03-26 ID IDW20000105A patent/ID24504A/id unknown
- 1999-03-26 EP EP99914884A patent/EP1003521A4/en not_active Withdrawn
- 1999-03-26 AU AU33533/99A patent/AU750010B2/en not_active Ceased
- 1999-03-26 CN CN99800823A patent/CN1273530A/zh active Pending
- 1999-03-26 CN CNA2004100867183A patent/CN1636598A/zh active Pending
- 1999-03-26 KR KR1020007000214A patent/KR20010021656A/ko not_active Ceased
- 1999-03-26 BR BR9906425-1A patent/BR9906425A/pt not_active IP Right Cessation
- 1999-03-26 PL PL99342969A patent/PL342969A1/xx unknown
- 1999-03-26 EA EA199901081A patent/EA004647B1/ru not_active IP Right Cessation
- 1999-03-26 HU HU0200547A patent/HUP0200547A3/hu unknown
- 1999-03-26 NZ NZ501987A patent/NZ501987A/xx unknown
- 1999-03-26 JP JP54936999A patent/JP2001508810A/ja not_active Ceased
- 1999-03-26 CA CA002295049A patent/CA2295049A1/en not_active Abandoned
- 1999-03-26 WO PCT/US1999/004275 patent/WO1999049869A1/en not_active Ceased
- 1999-03-26 IL IL13361299A patent/IL133612A0/xx not_active IP Right Cessation
- 1999-12-22 ZA ZA9907821A patent/ZA997821B/xx unknown
-
2000
- 2000-05-04 NO NO20002343A patent/NO20002343L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU3353399A (en) | 1999-10-18 |
| BR9906425A (pt) | 2000-07-11 |
| HUP0200547A3 (en) | 2003-07-28 |
| WO1999049869A1 (en) | 1999-10-07 |
| EA199901081A1 (ru) | 2000-12-25 |
| CN1273530A (zh) | 2000-11-15 |
| EP1003521A1 (en) | 2000-05-31 |
| NO20002343D0 (no) | 2000-05-04 |
| EP1003521A4 (en) | 2003-07-23 |
| KR20010021656A (ko) | 2001-03-15 |
| JP2001508810A (ja) | 2001-07-03 |
| NO20002343L (no) | 2000-05-04 |
| IL133612A0 (en) | 2001-04-30 |
| CN1636598A (zh) | 2005-07-13 |
| EA004647B1 (ru) | 2004-06-24 |
| ZA997821B (en) | 2000-08-01 |
| CA2295049A1 (en) | 1999-10-07 |
| HUP0200547A2 (hu) | 2002-07-29 |
| ID24504A (id) | 2000-07-20 |
| AU750010B2 (en) | 2002-07-11 |
| PL342969A1 (en) | 2001-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL140930A0 (en) | Compounds and compositions for delivering active agents | |
| AU2274201A (en) | Compounds and compositions for delivering active agents | |
| IL153297A0 (en) | Compounds and compositions for delivering active agents | |
| ATE406184T1 (de) | Arzneiverabreichungssystem | |
| EP0993831A3 (en) | Compounds and compositions for delivering active agents | |
| AU3492100A (en) | Oxadiazole compounds and compositions for delivering active agents | |
| AU4451101A (en) | Method and compositions for preventing hormone induced adverse effects | |
| MXPA03007837A (es) | Composiciones para suministrar bisfosfonatos. | |
| GEP20063773B (en) | Steroid Sulphatase Inhibitors | |
| CA2244209A1 (en) | Improved concentrated injection and infusion solutions for intravenous administration | |
| PL357944A1 (en) | Intradermal-penetration agents for topical local anesthetic administration | |
| WO2002028832A3 (en) | Diindolylmethane and c-substituted diindolylmethane compositions and methods for the treatment of multiple cancers | |
| MY125921A (en) | Compositions containing organic compounds | |
| MXPA03007857A (es) | Compuestos y composiciones para entregar agentes activos. | |
| IL140710A0 (en) | Pulmonary delivery of active agents | |
| NZ298769A (en) | use of progesterone-antagonistic and anti-estrogen compounds in a single dose for female contraception | |
| UA42806C2 (uk) | Система для одночасного трансдермального введення кількох активних начал | |
| WO2001030802A3 (en) | Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies | |
| AU2084801A (en) | Antiviral medication | |
| IL141914A0 (en) | Dosage form comprising liquid formulation | |
| AU2003253506A1 (en) | Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy | |
| AU8239298A (en) | Nucleotide-comprising composition | |
| AU6821687A (en) | System for delivering drug with enhanced bioacceptability | |
| IL140716A0 (en) | Use of inhibitors of protein kinase c epsilon to treat pain | |
| IL148513A0 (en) | Formulations for parenteral use of estramustine phosphate and amino acids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RENW | Renewal (renewal fees accepted) | ||
| PSEA | Patent sealed |